Meritage Portfolio Management’s CalciMedica CALC Stock Holding History

Meritage Portfolio Management’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$406K	Hold	61,539	–	–	0.03%	240
2025 Q3	$189K	Buy	61,539 +15,539	+34%	+$44.7K	0.01%	321
2025 Q2	$73.6K	Hold	46,000	–	–	﹤0.01%	316
2025 Q1	$87.9K	Hold	46,000	–	–	0.01%	312
2024 Q4	$163K	Hold	46,000	–	–	0.01%	319
2024 Q3	$204K	Hold	46,000	–	–	0.01%	327
2024 Q2	$182K	Hold	46,000	–	–	0.01%	326
2024 Q1	$191K	Hold	46,000	–	–	0.01%	334
2023 Q4	$132K	Buy	46,000 +36,000	+360%	+$104K	0.01%	329
2023 Q3	$27K	Hold	10,000	–	–	﹤0.01%	324
2023 Q2	$40K	Buy	+10,000	New	+$43.7K	﹤0.01%	336

Other funds holding CALC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Meritage Portfolio Management's CALC Position: Q4 2025 in Review

Meritage Portfolio Management held its CalciMedica (CALC) position steady in Q4 2025 at 61,539 shares worth $406K. The position accounts for 0.03% of the portfolio, ranked #240.

Meritage Portfolio Management first reported a position in CALC in Q2 2023 and has held it in 11 quarters since. 30 funds tracked by Wall St. Rank hold CALC as of Q4 2025.

Meritage Portfolio Management held 61,539 shares of CalciMedica worth $406K as of Q4 2025.
Meritage Portfolio Management left its CalciMedica share count unchanged in Q4 2025.
CalciMedica made up 0.03% of Meritage Portfolio Management's portfolio in Q4 2025, its #240 holding.
Meritage Portfolio Management first reported a position in CalciMedica in Q2 2023 and has held it in 11 quarters since.
30 funds tracked by Wall St. Rank held CalciMedica as of Q4 2025.

Based on Meritage Portfolio Management's 13F filing for Q4 2025, filed 27 Jan 2026.